Scout | DMDRP FY2026 Idea Development Award: Early-stage, high-risk DMD research (no clinical trials)

nofo

DMDRP FY2026 Idea Development Award: Early-stage, high-risk DMD research (no clinical trials)

The Duchenne Muscular Dystrophy Research Program (DMDRP) is funding early-stage “idea development” research with the potential for high impact in Duchenne muscular dystrophy (DMD). Applications must propose a well-justified, testable hypothesis and include required preliminary DMD-relevant data; clinical trials or clinical trial aims are not permitted. The program also encourages therapies tha…

Source

Agency: Defense Health Agency Contracting Activity - DHACA

Award

Total Funding: $2.5M

Dates

Open Date: June 17, 2026

Close Date: September 18, 2026

Eligibility

industry:defense

industry:research

Keywords

duchenne muscular dystrophy

dmdrp

idea development

high-risk research

preliminary data required

nonclinical research

translational therapies

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers